John R Fowler1, Mitchell G Maltenfort, Asif M Ilyas. 1. Department of Orthopaedics, University of Pittsburgh Medical Center, Kaufmann Medical Building, Suite 1010, 3471 Fifth Avenue, Pittsburgh, PA 15123, USA. johnfowler10@gmail.com
Abstract
BACKGROUND: The American Academy of Orthopaedic Surgeons (AAOS) recommends that surgeons obtain a confirmatory test in patients for whom carpal tunnel surgery is being considered. The AAOS, however, does not specify a preferred test. Ultrasound reportedly causes less patient discomfort and takes less time to perform, while maintaining comparable sensitivity and specificity to electrodiagnostic testing (EDX). QUESTIONS/PURPOSES: We determined whether ultrasound as a first-line diagnostic test is more cost-effective than using EDX alone or using ultrasound alone: (1) when used by a general practitioner; and (2) when used by a specialist. METHODS: A fictional population of patients was created and each patient was randomly assigned a probability of having true-positive, false-positive, true-negative, and true-positive ultrasound and EDX tests over an expected range of sensitivity and specificity values using Monte Carlo methods. Charges were assigned based on Medicare charges for diagnostic tests and estimates of missed time from work. RESULTS: The average charge for the use of ultrasound as a first-line diagnostic test followed by EDX for confirmation of a negative ultrasound test was $562.90 per patient in the general practitioner scenario and $369.50 per patient in the specialist scenario, compared with $400.30 and $428.30 for EDX alone, respectively. CONCLUSIONS: The use of diagnostic ultrasound as a first-line test for confirmation of a clinical diagnosis of carpal tunnel syndrome is a more cost-effective strategy in the specialist population and results in improved false-negative rates in the generalist population despite increased cost. LEVEL OF EVIDENCE: Level III, economic and decision analyses. See the Guidelines for Authors for a complete description of levels of evidence.
RCT Entities:
BACKGROUND: The American Academy of Orthopaedic Surgeons (AAOS) recommends that surgeons obtain a confirmatory test in patients for whom carpal tunnel surgery is being considered. The AAOS, however, does not specify a preferred test. Ultrasound reportedly causes less patient discomfort and takes less time to perform, while maintaining comparable sensitivity and specificity to electrodiagnostic testing (EDX). QUESTIONS/PURPOSES: We determined whether ultrasound as a first-line diagnostic test is more cost-effective than using EDX alone or using ultrasound alone: (1) when used by a general practitioner; and (2) when used by a specialist. METHODS: A fictional population of patients was created and each patient was randomly assigned a probability of having true-positive, false-positive, true-negative, and true-positive ultrasound and EDX tests over an expected range of sensitivity and specificity values using Monte Carlo methods. Charges were assigned based on Medicare charges for diagnostic tests and estimates of missed time from work. RESULTS: The average charge for the use of ultrasound as a first-line diagnostic test followed by EDX for confirmation of a negative ultrasound test was $562.90 per patient in the general practitioner scenario and $369.50 per patient in the specialist scenario, compared with $400.30 and $428.30 for EDX alone, respectively. CONCLUSIONS: The use of diagnostic ultrasound as a first-line test for confirmation of a clinical diagnosis of carpal tunnel syndrome is a more cost-effective strategy in the specialist population and results in improved false-negative rates in the generalist population despite increased cost. LEVEL OF EVIDENCE: Level III, economic and decision analyses. See the Guidelines for Authors for a complete description of levels of evidence.
Authors: Ethan R Wiesler; George D Chloros; Michael S Cartwright; Beth P Smith; Julia Rushing; Francis O Walker Journal: J Hand Surg Am Date: 2006 May-Jun Impact factor: 2.230
Authors: Michael Warren Keith; Victoria Masear; Kevin C Chung; Kent Maupin; Michael Andary; Peter C Amadio; William C Watters; Michael J Goldberg; Robert H Haralson; Charles M Turkelson; Janet L Wies; Richard McGowan Journal: J Bone Joint Surg Am Date: 2009-10 Impact factor: 5.284
Authors: Verena J M M Schrier; Stefanie Evers; Jennifer R Geske; Walter K Kremers; Hector R Villarraga; Ruud W Selles; Steven E R Hovius; Russell Gelfman; Peter C Amadio Journal: Ultrasound Med Biol Date: 2020-06-26 Impact factor: 2.998
Authors: Arnaldo Gonçalves de Jesus Filho; Bruno Fajardo do Nascimento; Marcelo de Carvalho Amorim; Ronald Alan Sauaia Naus; Elmano de Araújo Loures; Lucas Moratelli Journal: Rev Bras Ortop Date: 2014-09-16